---
title: "MODEC (TSE:6269) Is Up 9.1% After EPS Jumps On Strong Half-Year Results Has The Bull Case Changed?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296070792.md"
description: "MODEC (TSE:6269) shares rose 9.1% after reporting strong half-year results for the period ended June 30, 2026. Sales reached US$2,447.05 million and net income was US$224.05 million, both up year-over-year. Earnings per share increased to US$3.28 from US$2.12. While improved profitability supports dividend guidance, concerns remain regarding potential medium-term revenue declines and project concentration risks."
datetime: "2026-08-17T07:38:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296070792.md)
  - [en](https://longbridge.com/en/news/296070792.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296070792.md)
generator: "portal-rs"
---

# MODEC (TSE:6269) Is Up 9.1% After EPS Jumps On Strong Half-Year Results Has The Bull Case Changed?

-   MODEC, Inc. reported past half-year results for the period ended June 30, 2026, with sales of US$2,447.05 million and net income of US$224.05 million, both higher than the prior year period.
-   The company’s higher basic and diluted earnings per share from continuing operations, rising to US$3.28 from US$2.12, highlight improved profitability on a per-share basis.
-   We will now examine how MODEC’s stronger per-share earnings performance could shape the company’s investment narrative for investors.

Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.

## What Is MODEC's Investment Narrative?

For MODEC, you really have to believe in the long-term FPSO story and the company’s ability to convert its order book into resilient cash flows, even if headline revenue is expected to soften over the next few years. The latest half-year numbers, with higher sales, net income and EPS, reinforce the view that current projects are being executed efficiently and help underpin the recent step-up in dividend guidance. That said, the recent share price volatility and expectations for revenue to decline over the medium term keep contract timing, project execution and oil company capex cycles front and center as short term catalysts. The August earnings beat supports confidence in near-term profitability, but it does not remove the risk that a thinner project pipeline or delays could hit future earnings momentum.

However, that recent EPS strength does not fully offset concerns around project concentration and revenue decline risk. MODEC's shares have been on the rise but are still potentially undervalued by 38%. Find out what it's worth.

## Exploring Other Perspectives

TSE:6269 1-Year Stock Price Chart

The Simply Wall St Community’s two fair value estimates for MODEC span roughly ¥13,550 to ¥16,904, reminding you that private investor views can differ sharply. Set that against the recent earnings outperformance and ongoing concerns over a softer medium term revenue profile, and you can see why many readers may want to weigh multiple viewpoints before forming their own stance on the stock’s prospects.

Explore 2 other fair value estimates on MODEC - why the stock might be worth as much as 61% more than the current price!

## Form Your Own Verdict

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

-   A great starting point for your MODEC research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
-   Our free MODEC research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MODEC's overall financial health at a glance.

## Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

-   We've uncovered the 33 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
-   Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
-   AI is about to change healthcare. These 6 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.*

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [6269.JP](https://longbridge.com/en/quote/6269.JP.md)

## Related News & Research

- [Does FFRI Security (TSE:3692) Deserve A Spot On Your Watchlist?](https://longbridge.com/en/news/298082351.md)
- [What Is NEXTAGE Co., Ltd.'s (TSE:3186) Share Price Doing?](https://longbridge.com/en/news/297841313.md)
- [Shiseido Company (TSE:4911) Could Be 22% Undervalued Following New Serum Launch](https://longbridge.com/en/news/298111370.md)
- [Is ROHM (TSE:6963) Undervalued As New 650V IGBTs Meet A Richer P S Multiple?](https://longbridge.com/en/news/298060208.md)
- [JEOL (TSE:6951) Dropped, So What Is Driving Attention Now?](https://longbridge.com/en/news/297827691.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**